Who makes Isoetharine Hydrochloride?

Isoetharine Hydrochloride is developed by Roxane.

What development phase is Isoetharine Hydrochloride in?

Isoetharine Hydrochloride is FDA-approved (marketed).

What is the generic name of Isoetharine Hydrochloride?

isoetarine is the generic (nonproprietary) name of Isoetharine Hydrochloride.

Last reviewed 2026-04-20 · How we verify

Isoetharine Hydrochloride (isoetarine)

Roxane · FDA-approved active Quality 15/100

Isoetharine Hydrochloride, also known as isoetarine, is a small molecule drug that targets the beta-2 adrenergic receptor. Originally developed and currently owned by ROXANE, it was FDA approved in 1979 for treatment of asthma and chronic bronchitis. Isoetarine works by stimulating the beta-2 adrenergic receptor, leading to bronchodilation and improved lung function. As a proprietary medication, its commercial status is not generic, and its key safety considerations include potential cardiovascular effects and interactions with other medications.

At a glance

Generic name	isoetarine
Sponsor	Roxane
Drug class	isoetarine
Target	Beta-2 adrenergic receptor
Therapeutic area	Respiratory
Phase	FDA-approved
First approval	1979

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Isoetharine Hydrochloride CI brief — competitive landscape report
Isoetharine Hydrochloride updates RSS · CI watch RSS
Roxane portfolio CI